
Related Links
Individual Grant Program Main
Rules & Deadlines
2006 Recipients
Scientific Review Committee
Donate Now
Making a donation to Fight for Sight is easy and quick.
How would you like to donate?
> Online
> Mail a Donation
> Donate a Timeshare
Applications
Looking to fill out an application? Find it here:
> FFS / NANOS
|
|
Individual Grant Program Recipients
Summer Student |
Postdoctoral Fellowship | Grant-In-Aid
Summer Student Recipients - 2007
|
 |
Shuchi Agarwal,
who is a first year student at Boston University School of Medicine, will
work with Dr. John Danias, an Assoc. Professor of Ophthalmology at Mt. Sinai
School of Medicine. Her research attempts to identify genes involved in
glaucoma.
Her project: Immunohistochemical localization of proteins up-regulated in
the retina and optic nerve in glaucoma |
 |
Jihan Akhtar, a first year
medical student at the University of Illinois, will work with Dr. Deepak
Shukla, an Asst. Professor at the Dept. of Ophthalmology and Microbiology.
Her project involves a study of Herpes Simplex Virus infections affecting
the eye.
Her project: Mediators of HSV-1 entry into Human Conjunctival Epithelial
Cells |
 |
Michael Andreoli, enrolled
in the Accelerated Medical Program (BA/MD) at Boston University, is working
in Dr. Meg DeAngelis’ laboratory at Harvard’s Massachusetts Eye & Ear
Institute. His study involves identifying genes responsible for age-related
macular degeneration.
His project: Genetic Analysis of Sib-pairs extremely discordant for
Age-Related Macular Degeneration |
 |
Almeria Decker, a second
year medical student at the Indiana University, is working in the Dept. of
Ophthalmology with Dr. Xiaoxi Qiao. She will determine if a drug that has
successfully treated some of the symptoms of Lou Gehrig’s disease will be
useful in the treatment of age-related macular degeneration.
Her project: Evaluating the effect of Minocycline on a rat model of
Age-related Macular Degeneration |
 |
Corinne Decker is an
undergraduate in biotechnology at the University of Delaware. She will work
with Dr. Melinda Duncan in the Biological Sciences at the Univ. of Delaware
to study of the development of secondary cataracts, or posterior capsule
opacification.
Her project: The role of βB2-crystallin in epithelial-mesenchymal
transition |
 |
Meenakashi Gupta, a third year medical student
at Harvard Medical School, will work with Dr. Douglas Rhee, an Asst.
Professor at the Massachusetts Eye & Ear Infirmary. Ms. Gupta’s project
will involve studying the cellular causes for increased intraocular pressure
in glaucoma patients.
Her project: Testing
the role of SPARC in intraocular pressure regulation in trabecular meshwork
and uveoscleral tract using Dexamethasone and Latanoprost in SPARC-null mice |
 |
Alice
Irby,
who received her second Summer Student Fellowship in 2007, is a graduate
student in Vision Science at the University of Alabama. She will work with
Dr. Kent Daum in the School of Optometry at UAB. Her project involves
predicting the prevalence of glaucoma among certain residents of Alabama.
Her project: Role of ocular and systemic variables and
socio-economic status in the intraocular pressure of adults in the Alabama
Black Belt |
 |
Thomas
Johnson,
received his second Summer Student Fellowship in 2007. He is a graduate
student at the Centre for Brain Repair at Cambridge University, under the
direction of Dr. Keith Martin. His project involves stem cell
transplantation as a possible treatment for glaucoma.
His project:
Characterization of the responses of human bone marrow-derived mesenchymal
stem cells and human fetal-derived neural progenitor cells to intravitreal
transplantation in a rat model of laser-induced glaucoma |
 |
Kevin
Joseph
is an undergraduate majoring in Biology at St. Louis University. He will
work with Dr. Judith Ogilvie, an Asst. Professor in the Dept. of Biology at
SLU. His project involves the study of a specific gene that is expressed in
individuals with Retinitis Pigmentosa.
His project:
Ptpro Localization in Wild Type and rd1 mouse retina |
 |
Troy
Kapral
is a first year medical student at the Medical College of Georgia. His
project, with Dr. Bala Ambati, Asst. Professor of Ophthalmology at the MCG,
involves a study of the growth of abnormal blood vessels in the cornea.
His project:
MMP-1, Ets-1 and DNA synthesis suppression by intraceptor interference of
VEGF in corneal angiogenesis |
 |
Tiffany
Liu,
an undergraduate majoring in Molecular Biology at Pomona College, will work
with Dr. Matt LaVail, Prof. of Ophthalmology at Univ. of California San
Francisco. Her project involves a novel treatment for an animal model of
inherited and age-related retinal disease.
Her project:
Combination of CNTF and BDNF in the rescue of mutant rhodopsin transgenic
rat photoreceptors |
 |
Patrick
McLaren,
an undergraduate majoring in ecology at the University of Michigan, will
work with Dr. Julia Richards, Assoc. Professor at the Kellogg Eye Center.
His project will involve identifying genes that may play a role in glaucoma.
His project: Sequence variants in CLCN3 and the associated
risk of glaucoma |
 |
Julie
Mocko,
an undergraduate majoring in Neuroscience at Northeastern University, will
spend the summer working in the lab of Dr. Anne Fulton, Assoc. Professor of
Ophthalmology at Children’s Hospital in Boston. Ms. Mocko’s project
involves a study of the abnormal vasculature and growth factors seen in some
premature infants.
Her project: The molecular basis for neurovascular
abnormalities in Retinopathy of Prematurity |
 |
Amar
Patel
is a third year medical student at Wake Forest University. He will work
with Dr. Keith Walter, Asst. Professor at the Wake Forest Eye Center. His
research involves a review of certain factors that impact the outcome of
LASIK surgery in myopic patients.
His project:
Effect of environmental factors on myopic LASIK enhancement rates |
 |
Jared
Peterson,
a third year medical student at the Ohio State University College of
Medicine, will work with Dr. Cynthia Roberts, an Assoc. Professor of
Ophthalmology at OSU. His study will analyze recorded intraocular pressures
in patients over several years to determine the impact of advancing age on
elevated IOP.
His project: The influence of age on Goldmann Applanation
Tonometry measurement – a longitudinal study |
 |
Parvathy Pillai
is a third year medical student at the University of Miami. She will work
with Dr. Richard Lee, an Asst. Professor of Ophthalmology at the Bascom
Palmer Eye Institute. Her project involves a novel screening technique for
patients likely to develop glaucoma.
Her project: Biomechanical properties of the corneal and
ocular disease |
 |
David
Ramsey
is a MD/PhD student at the University of Illinois. He will work with Dr.
Haohua Qian, Assoc. Professor of Neuroscience at UIC. His study involves
the genetic basis of nerve cell changes in patients with diabetic
retinopathy.
His project: The molecular basis for visual dysfunction in
the GABA Signaling Pathway in Diabetes |
|
 |
Aaron
Sabolch
is a second year medical student at the University of Michigan. This
summer, he will work with Dr. Anand Swaroop, Professor of Ophthalmology at
the Kellogg Eye Center. He will attempt to increase our understanding about
the role certain proteins in the development of retinal photoreceptors.
His project:
Novel leucine-rich repeat transmembrane proteins as potential modulators of
photoreceptor differentiation |
 |
George
Thomas
is an
undergraduate majoring in molecular biology at the University of Michigan.
His research project, under the direction of Dr. Anand Swaroop, Prof. of
Ophthalmology at the Kellogg Eye Center, involves using a mouse model to
learn more about the genes responsible for Retinitis Pigmentosa, an
inherited retinal disease.
His project:
Screen for human mutations in RD11, the gene responsible for the RD11 mouse
retinopathy |
 |
Thuydung Trinh
is a
first year medical student at Creighton University. She will work with Dr.
James Rosenbaum, Prof. of Ophthalmology at the Casey Eye Institute at the
Oregon HSU, to establish a mouse model for uveitis, an inflammation inside
the eye, often associated with auto-immune disorders such as juvenile
arthritis and MS.
Her
project: Induction of anterior uveitis by transfer of MOG specific T and B
cells into the Th x 2D2 transgenic mice |
 |
Ilene
Tsui,
an undergraduate majoring in Chemistry at Wellesley College, will work with
Dr. Janet Sparrow, Prof. of Ophthalmology at Columbia University. Her
project involves identifying certain molecular changes that may trigger
age-related macular degeneration.
Her project:
RPE lipofuscin and inflammatory mechanisms in age-related macular
degeneration |
|

|
Melissa
Velarde,
an
undergraduate pre-med studying at Pensacola Christian College will work with
Dr. Jeffrey Goldberg, Asst. Professor at the Univ. of Miami’s Bascom Palmer
Eye Institute. She will investigate why certain retinal cells do not
regenerate; understanding this will be useful in treating optic nerve
injuries and degenerative disease.
Her Project:
The role of an IQ motif protein in the axon growth ability of retinal
ganglion cells |
 |
Wes
Waxweiler,
a first
year medical student at the Medical College of Georgia, will work this
summer with Dr. John Nickerson, Assoc. Prof. of Ophthalmology at Emory
University. His project explores testing novel approaches to drug delivery
into the retina.
His project:
Gene delivery rates into the retina: as examined with subretinal vs.
peribulbar injection sites as well as with synthetic vectors |
 |
Jonathan Weiner
is an undergraduate at the University of Pennsylvania, majoring in Biology.
He will work with Dr. Eric Pierce, an Asst. Professor of Ophthalmology at
the Univ. of Penn. His study involves the study of a genetic mutation that
causes Retinitis Pigmentosa.
His project:
Mechanism and treatment of Retinitis Pigmentosa 1. |
 |
Joshua
Zaffos,
an undergraduate from the University of Georgia who is majoring in
nutrition, will work with Dr. Henry Edelhauser at the Emory Eye Center. His
study involves a study to determine how anti-cancer drugs diffuse across the
eye which may provide physicians an alternative method to treat eye
tumors.
His project:
Transscleral delivery of the anti-cancer drugs Vinblastine and Doxorubicin |
_____________________________________________________
Postdoctoral Fellowship Recipients - 2007
 |
Christian Antolik, PhD
Schepens Eye Research Institute
Manipulation of insulin-like
growth factor (IGF) signaling molecules to promote optic nerve regeneration
Patients with glaucoma suffer vision
loss from damage to cells in the optic nerve. Dr. Antolik proposes to
characterize the function of a protein that may impact the growth of optic
nerve cells. He hopes to determine whether this protein can stimulate optic
nerve generation. Dr. Antolik received his PhD in Physiology from the
University of Maryland. He will work in Dr. Dong Chen’s laboratory at
Harvard’s Schepens Eye Research Institute. |
 |
Marisol Cano, PhD
Wilmer Eye Institute / Johns Hopkins
Novel Anti-angiogenic peptides for
the treatment of choroidal neovascularization
Age-related macular degeneration is one
of the most common causes of blindness among seniors. New therapies have
been introduced which limit the neovascularization or new blood vessel
growth which occur in this disease. Dr. Cano will
evaluate the anti-angiogenic properties of several peptides in an effort to
identify additional treatment modalities.
Dr. Cano received her PhD
in molecular medicine. She will work with Dr. Peter Gehlbach in the Retina
Division of the Wilmer Eye Institute. |
 |
Jennifer Chao, MD, PhD
Doheny Eye Institute/USC – Caltech
Corneal Plasticity:
characterization of the multi-potentiality of human keratocytes
Stem cells may provide a useful
alternative to corneal transplantation for blinding eye diseases that result
in scarring or opacities to the cornea. Marianne Bronner-Fraser, PhD, a
developmental biologist at Caltech, has differentiated stem cells in a bird
model, and hopes to apply this principle of remodeling, translating these
promising results to the human cornea. Her postdoctoral fellow is Dr.
Jennifer Chao, who received her MD and PhD in Neuroscience from Yale. She
completed her residency in ophthalmology at Doheny Eye Institute and is now
a clinical fellow there. |
 |
Samuel Crish, PhD
Vanderbilt University
Glaucoma: a disease of the eye
that begins in the brain
Elevated Intraocular Pressure (IOP) is a
risk factor of glaucoma, and often results in damage to the optic nerve.
Using an animal model, Dr. Crish will measure how increased IOP results in
damage or loss to the retinal ganglion cells which transfer visual
information to the brain. Dr. Crish completed his PhD in Neurobiology at
the University of Illinois. His mentor is Dr. David Calkins, a Fight for
Sight alumni, whose laboratory investigates the neurobiology of glaucoma. |
 |
Clifton Dalgard
University of California, San Francisco
High-throughput screening of a
molecule library for identification and characterization of novel
Rb therapeutics
Retinoblastima is the most common eye
cancer in childhood. Radiation was the traditional therapy for these
patients, however there was a risk of secondary tumors. Today, a
combination of radiation and chemotherapy is the preferred treatment. Dr.
Dalgard will test a number of chemicals for their potential in effectively
treating retinoblastoma tumor cells. He received his PhD in Neuroscience at
the Uniformed Services University. His mentor for this project is Dr. Joan
O’Brien, who directs the Ocular Oncology unit at UCSF. |
 |
Rolf Herrmann
Duke University
Rod light adaptation: Is dopamine
involved?
Misbalance in light adaptation is seen
in some disorders, such as photophobia, and is a characteristic of some
diseases such as RP. This projects aims to understand, on a cellular and
molecular level, how retinal cells adjust their sensitivity to changing
ambient light, from moonlight to bright sunlight. Dr. Hermann received his
PhD in Biophysics from Germany. His sponsor for this project is Dr. Vadim
Arshavsky, Professor of Ophthalmology and Pharmacology at Duke. |
 |
Aihua Jiang
Indiana University
Studying the activation of retinal
vascular endothelial cells in a mouse model of retinal angiomatous
proliferation
A subgroup of individuals with
age-related macular degeneration develop abnormal blood vessel growth –
retinal angiomatous proliferation (RAP). Using an animal model, Dr. Jiang
will seek molecular targets to treat this disease. Dr. Jiang received her
MD and PhD from China. She will work with Dr. Xiaoxi Qiao, Assistant
Professor in the Indiana University Department of Ophthalmology. |
 |
Colin Scott
University of Iowa
Diagnosis and Grading of
Papilledema in patients with raised intracranial pressure using Optical
Coherence Tomography (OCT) compared to clinical expert assessment
Papilledema, or swelling of the optic
disc, can lead to permanent loss of vision. The disorder is generally
diagnosed by clinical examination or photographs. OCT may provide an
objective method to measure optic nerve edema and monitor treatment
interventions. Dr. Scott received his MD from the Medical University of
Ohio and completed a neurology residency at the University of Wisconsin.
Dr. Scott will work on this project during his neuro-ophthalmology
fellowship with Dr. Michael Wall, a Professor of Neurology and Ophthalmology
at the University of Iowa. |
 |
Yureeda Qazi
Medical College of Georgia
Use of Nanoparticles expressing
Flt Intraceptors to Suppress Corneal Angiogenesis
This project will test the use of a
unique drug delivery system through the use of nanoparticles carrying
plasmids that inhibit abnormal blood vessel growth. Current treatments for
corneal angiogenesis are neither practical nor effective. A successful,
long-term method to deliver therapeutics would have applications in treating
many eye diseases. Dr.Qazi graduated from medical school in Pakistan and
will work with Dr. Bala Ambati, FFS Alumni and Associate Professor in the
Department of Ophthalmology at the Medical College of Georgia. |
 |
Felix Vazquez-Chona
University of Utah
Modulation of Muller glia using
cell cyclte inhibitors
Retinal trauma or degeneration through
disease can cause the death or scarring of Muller glial cells. Finding a
way to reverse and prevent glial activity are keys to a successful strategy
for retinal repair. This project will test compounds that block Muller
glial cell overactivation. Dr. Vazquez-Chona received his PhD in
Neurobiology from the University of Tennessee and will be a postdoc in the
labs of Drs. Robert Marc and Edward Levine at the John Moran Eye Center of
the University of Utah. |
_____________________________________________________
Grant-In-Aid Recipients - 2007
 |
Organization and Function of the Whirlin
Supramolecular Complex in Photoreceptors
Jun Yang, PhD
Instructor in Ophthalmology
Massachusetts Eye & Ear Infirmary / Harvard University
Usher Syndrome is an
inherited disease that causes both blindness and deafness. To date, there
is no cure. Dr. Yang proposes to study one of the genes responsible for
Usher Syndrome, with the hope of identifying potential gene therapy targets. |
 |
Space Perception and Cortical Organization in
Patients with Retinal Degeneration
Michael Silver, PhD
Assistant Professor of Neuroscience and Optometry
University of California, Berkeley
This project involves
study of the reorganization in brains of patients with retinal diseases.
Dr. Silver will compare the MRIs of patients who must cope with the loss of
vision with Retinitis Pigmentosa, a disease that results in the loss of the
peripheral visual field and Stargardt’s disease, which results in the loss
of the central visual field. |
 |
Studies of the AIPL1-based chaperone system in
retinal photoreceptor cells
Xiaoqing Liu, PhD
Assistant Research Scientist
Retina Foundation of the Southwest
Dr.
Liu will study one of the genes responsible for the inherited disorders,
Retinitis Pigmentosa. Understanding the molecular mechanisms that result in
early photoreceptor death may shed light on possible gene therapies for this
and other blinding eye diseases. |
 |
Femtosecond Laser-Assisted Keratoplasty
Shahzad Mian, MD
Assistant Professor of Ophthalmology
Kellogg Eye Center / University of Michigan
Corneal transplant is the
most effective means to restore vision to patients who suffer disease or
trauma to the cornea. Rather than the current method of surgical blades and
sutures, Dr. Mian proposes to utilize an ultrafast laser to assist in more
precisely fitting the donor tissue to the patient cornea. |
 |
Modulation of TLR mediated innate immune response in
human corneal epithelial cells under high glucose conditions
Ashok Kumar, PhD
Research Scientist
Kresge Eye Institute / Wayne State University
There is evidence that
people with poorly-controlled diabetes are prone to infectious keratitis, a
bacterial infection of the cornea. Untreated, keratitis can lead to vision
loss and blindness. Dr. Kumar’s project will investigate the molecular and
cellular basis of keratitis in diabetics and may provide insights into new
therapies to combat this infection. |
 |
Neurotrophic growth factor-secreting stem cell
transplants for treatment of glaucoma
Sinisa Grozdanic, DVM, PhD
Research Assistant Professor
Iowa State University College of Veterinary Medicine
Nerve cell death is
responsible for vision loss in several eye diseases, including glaucoma and
retinal disease. In this project, Dr. Grozdanic will transplant stem cells
to replace lost never cells or to act as support cells as a means of
treating certain eye diseases. |
 |
Imaging the effects of cone opsin mutations on the
integrity of the cone photoreceptor mosaic
Joseph Carroll, PhD
Assistant Professor of Ophthalmology
Medical College of Wisconsin
This project will
characterize and catalog cone mutations in order to further increase our
understanding of retinal disease. Dr. Carroll has developed an imaging
approach that will provide information about early cellular changes to the
retina, before any loss of vision can be detected. |
 |
Local versus systemic blockage of T-cell
costimulation in experimental autoimmune uveitis
Thomas Albini, MD
Assistant Professor of Ophthalmology
Bascom Palmer Eye Institute / Univ. of Miami
Uveitis or infections of
the eye are treated with a multitude of products. In this study of
autoimmune uveitis, Dr. Albini will assess the toxicity of Abatacept, a
newly approved pharmaceutical that has been used successfully in treating
patients with rheumatoid arthritis. He will compare the efficacy of
intravenous injection versus an intravitreal injection of the agent. |
|